Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01667419 |
Title | BRIM8: A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma |
Acronym | BRIM8 |
Recruitment | Completed |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | SWE | POL | NZL | NOR | NLD | ITA | ISR | IRL | HRV | GBR | FRA | EST | ESP | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS | ARG |